init thought nonimmunogen recombin aaa emerge office vector candid treat monomer disease clear howe induce potent immune response transfer product lead destruct transduc cell therefore develop strategy circuit facility longterm express transfer therapeutic protein main challenge gene therapy value herein strategy inhibit under active follow muscle transfer administer claim block costimulatori signal require early prime use pd ligand cell function tissue site provide proof principal combine immunoregulatori target two nonredund checkpoint response ie effector improv persist experiment set cytotox escape init blocked pl pdl metres candid approach bottleneck direct toward 